Ofev or Esbriet Can Help Stabilize Lung Function in Advanced IPF

Ofev or Esbriet Can Help Stabilize Lung Function in Advanced IPF

301737

Ofev or Esbriet Can Help Stabilize Lung Function in Advanced IPF

Decline in lung function is slower in people with advanced idiopathic pulmonary fibrosis (IPF) who start treatment with Ofev (nintedanib) or Esbriet (pirfenidone), although their risk of death remains considerably greater than those with mild to moderate disease, a study based on patient data reported. Data from patient registries in four Nordic countries — Denmark, Finland, Norway, and Sweden — included people with severely impaired lung function, who are typically excluded from clinical trials of therapies,…

You must be logged in to read/download the full post.